Cancer-related fatigue (CRF) is a common and distressing symptom that can persist after cancer treatment has concluded. Bright light therapy has shown preliminary efficacy in reducing CRF, but its impact on other psychosocial factors is unclear. The purpose was to examine the impact of a 1-month light therapy intervention on fatigue, mood, and quality of life in cancer survivors with fatigue. This study, along with previous reports of light therapy for CRF, support the use of this intervention to improve fatigue in cancer survivors.
1. The LITE Study: Rationale and Protocol for a Randomized Controlled Trial of Light Therapy for Cancer-Related Fatigue in Cancer Survivors
2. Bright Light Therapy Improves Cancer-Related Fatigue in Cancer Survivors: A Randomized Controlled Trial
3. Effects of a Light Therapy Intervention on Diurnal Salivary Cortisol in Fatigued Cancer Survivors: A Secondary Analysis of a Randomized Controlled Trial
SLEEP 2018 - 0864 A Randomized Controlled Trial of Light Therapy for Insomnia Symptoms in Fatigued Cancer Survivors
Primary Investigator:
Jillian A Johnson, PhD (Department of Biobehavioral Health, College of Health and Human Development, Pennsylvania State University, University Park, PA, USA)
Co-Investigators:
Sheila N Garland, PhD (Department of Psychology, Faculty of Science, MUN, Division of Oncology, Faculty of Medicine, MUN)
Linda E Carlson, PhD (Department of Psychology, Faculty of Arts, University of Calgary, Department of Oncology, Cumming School of Medicine, University of Calgary)
Josée Savard, PhD (School of Psychology, Faculty of Social Sciences, Université Laval)
Steven A Simpson, PhD (Department of Oncology, Cumming School of Medicine, University of Calgary; Department of Psychiatry, Cumming School of Medicine)
Sonia Ancoli-Israel, PhD (Departments of Psychiatry and Medicine, University of California San Diego)
Tavis S Campbell, PhD (Department of Psychology, Faculty of Arts, University of Calgary; Department of Oncology, Cumming School of Medicine, University of Calgary)
Those on our mailing list will be the first to receive information about new studies, interesting findings from past studies, and more!